Microscopic Colitis: Epidemiology and Treatment

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Microscopic colitis, a chronic diarrheal condition, is characterized by colonic intraepithelial lymphocytosis, expansion of the lamina propria with acute and chronic inflammatory cells, and preserved crypt architecture. These changes, in association with a thickened subepithelial collagen band, are termed collagenous colitis, whereas changes occurring without a thickened collagen band are classified as lymphocytic colitis. Population-based epidemiologic studies confirm that microscopic colitis is most frequently diagnosed in middle-aged or elderly women and that its incidence is rising. Although these disorders diminish patients' quality of life, they are not associated with an increased risk of colorectal cancer, and survival is not diminished. Clinical and histologic improvement after therapy have been noted in one randomized trial of bismuth subsalicylate and three randomized clinical trials of oral delayed-release budesonide. A treatment algorithm for microscopic colitis is proposed.

Original languageEnglish (US)
JournalAmerican Journal of Gastroenterology
Volume98
Issue number12 SUPPL.
DOIs
StatePublished - Dec 2003

Fingerprint

Microscopic Colitis
Epidemiology
Lymphocytic Colitis
Collagen
Collagenous Colitis
Lymphocytosis
Budesonide
Epidemiologic Studies
Colorectal Neoplasms
Mucous Membrane
Therapeutics
Randomized Controlled Trials
Quality of Life
Survival
Incidence
Population

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Microscopic Colitis : Epidemiology and Treatment. / Loftus, Jr, Edward Vincent.

In: American Journal of Gastroenterology, Vol. 98, No. 12 SUPPL., 12.2003.

Research output: Contribution to journalReview article

@article{0169b9a04a9a445db281c2369c87e394,
title = "Microscopic Colitis: Epidemiology and Treatment",
abstract = "Microscopic colitis, a chronic diarrheal condition, is characterized by colonic intraepithelial lymphocytosis, expansion of the lamina propria with acute and chronic inflammatory cells, and preserved crypt architecture. These changes, in association with a thickened subepithelial collagen band, are termed collagenous colitis, whereas changes occurring without a thickened collagen band are classified as lymphocytic colitis. Population-based epidemiologic studies confirm that microscopic colitis is most frequently diagnosed in middle-aged or elderly women and that its incidence is rising. Although these disorders diminish patients' quality of life, they are not associated with an increased risk of colorectal cancer, and survival is not diminished. Clinical and histologic improvement after therapy have been noted in one randomized trial of bismuth subsalicylate and three randomized clinical trials of oral delayed-release budesonide. A treatment algorithm for microscopic colitis is proposed.",
author = "{Loftus, Jr}, {Edward Vincent}",
year = "2003",
month = "12",
doi = "10.1016/j.amjgastroenterol.2003.10.008",
language = "English (US)",
volume = "98",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12 SUPPL.",

}

TY - JOUR

T1 - Microscopic Colitis

T2 - Epidemiology and Treatment

AU - Loftus, Jr, Edward Vincent

PY - 2003/12

Y1 - 2003/12

N2 - Microscopic colitis, a chronic diarrheal condition, is characterized by colonic intraepithelial lymphocytosis, expansion of the lamina propria with acute and chronic inflammatory cells, and preserved crypt architecture. These changes, in association with a thickened subepithelial collagen band, are termed collagenous colitis, whereas changes occurring without a thickened collagen band are classified as lymphocytic colitis. Population-based epidemiologic studies confirm that microscopic colitis is most frequently diagnosed in middle-aged or elderly women and that its incidence is rising. Although these disorders diminish patients' quality of life, they are not associated with an increased risk of colorectal cancer, and survival is not diminished. Clinical and histologic improvement after therapy have been noted in one randomized trial of bismuth subsalicylate and three randomized clinical trials of oral delayed-release budesonide. A treatment algorithm for microscopic colitis is proposed.

AB - Microscopic colitis, a chronic diarrheal condition, is characterized by colonic intraepithelial lymphocytosis, expansion of the lamina propria with acute and chronic inflammatory cells, and preserved crypt architecture. These changes, in association with a thickened subepithelial collagen band, are termed collagenous colitis, whereas changes occurring without a thickened collagen band are classified as lymphocytic colitis. Population-based epidemiologic studies confirm that microscopic colitis is most frequently diagnosed in middle-aged or elderly women and that its incidence is rising. Although these disorders diminish patients' quality of life, they are not associated with an increased risk of colorectal cancer, and survival is not diminished. Clinical and histologic improvement after therapy have been noted in one randomized trial of bismuth subsalicylate and three randomized clinical trials of oral delayed-release budesonide. A treatment algorithm for microscopic colitis is proposed.

UR - http://www.scopus.com/inward/record.url?scp=0347415660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347415660&partnerID=8YFLogxK

U2 - 10.1016/j.amjgastroenterol.2003.10.008

DO - 10.1016/j.amjgastroenterol.2003.10.008

M3 - Review article

C2 - 14697916

AN - SCOPUS:0347415660

VL - 98

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12 SUPPL.

ER -